United States · FDA National Drug Code directory
ZILBRYSQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-992_49eeeabf-4c62-63cb-e063-6394a90a8248
- Product NDC
- 50474-992
- Form
- INJECTION, SOLUTION
- Composition / generic term
- zilucoplan
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240103
- Source listing expiry
- 20271231
Source-listed ingredients
- ZILUCOPLAN — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 BOX (50474-992-80) / 7 SYRINGE, GLASS in 1 CARTON / .81 mL in 1 SYRINGE, GLASS · 50474-992-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →